More than 50,000 containers of a widely sold pain-relief ointment are being pulled from shelves as federal safety officials warn it poses a serious risk to children.
The U.S. Consumer Product Safety Commission is recalling Mamisan Pain Relieving Topical Ointment due to the product’s packaging failing to meet federal child-resistant standards.
The ointment contains lidocaine, a medication that can cause serious harm — or even death — if ingested by young children.
“The ointment’s packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children,” the CPSC warns.
Consumers are advised to immediately secure the recalled products out of the sight and reach of children and contact Plantimex for a free replacement lid.
Read more: Company files bankruptcy weeks after refusing to recall products linked to fire, explosions
The product was sold at Walmart and Target stores nationwide and online between April 2024 and October 2025 for about $10.
The recalled product comes in a 3.52-ounce jar labeled “Mamisan Pain Relieving Topical Ointment” with UPC number 860006498115.
While no injuries have been reported, safety officials are urging consumers to take immediate action by storing the recalled products away from children and contacting Plantimex for a new lid.
Plantimex can be contacted at 855-752-6869 from 9 a.m. to 4 p.m., Monday through Friday.
Consumers may also email customercare@plantimexusa.com with the subject line “RECALL.”